Surescripts Completes Settlement with Federal Trade Commission

Surescripts has settled its case with the Federal Trade Commission (FTC), without any monetary penalties, constituting the completion of all issues raised in the complaint brought by the FTC in early 2019.

โ€œSurescripts is proud to have pioneered electronic prescribing that has brought enormous value to patients and care providers alike. For more than two decades, Surescripts has delivered innovations that increase patient safety, lower costs and ensure quality care,โ€ said Frank Harvey, Chief Executive Officer of Surescripts. โ€œWeโ€™re pleased that this agreement brings an end to the FTCโ€™s litigation, formalizing changes to our business practices that we started several years ago, including the elimination of loyalty provisions in contracts. We are committed to continuous innovation and remain focused on serving our customers who make up the Surescripts Network Alliance and ultimately the patients they serve.โ€

The FTCโ€™s case relied on significant factual errors about Surescriptsโ€™ business and mischaracterizations about the economic realities of the e-prescribing market. Since 2009, Surescripts has reduced average E-Prescribing transaction fees by 77%, and since 2016, Surescripts has improved the accuracy of electronic prescriptions more than 200%.

โ€œAs a trusted health information network, Surescripts helps doctors, pharmacists and other healthcare providers communicate with each other as a team, sharing information to increase patient safety, lower costs and ensure quality care,โ€ said Harvey. โ€œWe look forward to continuing to simplify health intelligence sharing and bring even greater innovation and experience to the healthcare industry.โ€

Surescripts has enabled valuable patient clinical and benefit intelligence sharing, including the transmission of COVID-19 diagnosis reports between providers and public health agencies nationwide and the transmission of real-time prescription benefit information to save patients money.

Learn more about how Surescripts is driving innovation in Surescripts 2022 National Progress Report.

About Surescripts

Our purpose is to serve the nation through simpler, trusted health intelligence sharing, in order to increase patient safety, lower costs and ensure quality care. At Surescripts, we align healthcare organizations across the nation and convene the Surescripts Network Allianceยฎ to give healthcare professionals the trusted insights they need to serve patients. Together, weโ€™re making interoperability an everyday reality, making it simpler to choose medications patients can afford and adhere to, and getting specialty medications to patients more efficiently. Visit us at surescripts.com and follow us at twitter.com/surescripts.

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  246.29
+4.73 (1.96%)
AAPL  259.04
-1.29 (-0.50%)
AMD  204.68
-5.34 (-2.54%)
BAC  56.18
+0.54 (0.97%)
GOOG  326.01
+3.58 (1.11%)
META  646.06
-2.63 (-0.41%)
MSFT  478.11
-5.36 (-1.11%)
NVDA  185.04
-4.07 (-2.15%)
ORCL  189.65
-3.19 (-1.65%)
TSLA  435.80
+4.39 (1.02%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Gift this article